1. Scrip
  2. >>Business

Pharma Stands Up To Trump Pressure With COVID-19 Vaccines Science Pledge

New US Poll Shows Public Distrust

 
• By Andrew McConaghie

CEOs from the most advanced vaccines developers pledge to maintain standards – for the sake of safety, efficacy and public trust in vaccines.

single Sars-cov-2 coronavirus vaccine
The timing of a potential approval has become a political issue ahead of the election - and is undermining US public faith in COVID-19 vaccines.

Chief executives of nine US and European biopharma companies leading COVID-19 vaccines development have come together to pledge that safety and efficacy will not be compromised in order to gain rapid approval for their products.

The companies include Pfizer Inc./BioNTech SE, Moderna, Inc

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Business

More from Scrip

Lupin CEO On Trump’s Most Favored Nation Policy, Tariffs, Firm’s Five-Year Plan

 
• By Vibha Ravi

Lupin CEO Vinita Gupta speaks on Trump’s most favored nation policy, the Inflation Reduction Act’s “pill penalty” and other developments in the US, a major market for the company. The company also outlines a five-year plan focused on complex generics and technology platforms.

Novo Nordisk’s CEO Forced Out After Falling Behind In GLP-1 Battle

 
• By Andrew McConaghie

Company surprises investors with Jørgensen's exit but insists its strategy will not change.

In Brief: US FDA Delay Sends Biohaven Shares Down

 
• By Andrew McConaghie

The US regulator’s decision has taken Biohaven and investors by surprise, with the reason for a ‘major amendment’ status not clear.